When I think of the value of the Precision Medicine Initiative that President Obama announced earlier this year, the money involved isn’t the first thing that comes to mind (although over $200 million in proposed dollars to entities like the National Institutes of Health (NIH) and the National Cancer Institute are worth cheering). Actually, the focus on precision medicine provides a tremendous opportunity to take a step back and consider the future of research, medicine and the life sciences.
That’s exactly what we’re going to be doing over the next several days here in the Disruptive Women in Health Care space. Experts from a variety of health related sectors and with diverse perspectives are going to be sharing their views on “Re-Imagining the Life Sciences and Research.” We need discussions like this because, while the potential in this field is truly breathtaking and difficult to fully comprehend, there are critical unanswered questions. (more…)